Furthermore, the CD4+ and CD8+ cell population and tumor‐associated macrophages (F4/80+) in tumor tissues were decreased after treatment of ZrC@prodrug, implying that the intratumor immune response was also altered in TME. The gene discussed is CD4; the disease is neoplasm.